Author

R. Bringas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

B.-R. J. Iraldo· 1 shared D. Palenzuela· 1 shared D. Vazquez-Blomquist· 1 shared J. Fernandez-de-Cossio· 1 shared J. Miranda· 1 shared L. I. Novoa· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B.-R. J. Iraldo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

HeberFERON distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MG.

J. Miranda, D. Vazquez-Blomquist, R. Bringas, J. Fernandez-de-Cossio, D. Palenzuela, L. I. Novoa, B.-R. J. Iraldo

This paper identifies molecular mechanisms of HeberFERON's distinct effect on the glioblastoma cell line U-87MG, showing its unique impact on the cell cycle.

bioRxiv · Sep 22, 2022 · PreprintCancer Biology